OCUL icon

Ocular Therapeutix
OCUL

Overview Fund Activity

131 hedge funds and large institutions have $215M invested in Ocular Therapeutix in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 24 closing their positions.

Holders
131
Holders Change
-9
Holders Change %
-6.43%
% of All Funds
2.07%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
15
Increased
44
Reduced
43
Closed
24
Calls
$771K
Puts
$883K
Net Calls
-$112K
Net Calls Change
-$43K

Top Buyers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$3.08M
2
Millennium Management
2
Millennium Management
New York
$3.64M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.53M
4
Los Angeles Capital Management
4
Los Angeles Capital Management
California
$1.73M
5
EA
5
Emerald Advisers
Pennsylvania
$6.4M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$1.1M
2
Man Group
2
Man Group
United Kingdom
$0
3
CSS
3
Cubist Systematic Strategies
Connecticut
$165K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$306K
5
Voloridge Investment Management
5
Voloridge Investment Management
Florida
$866K
Name Market Value Shares Shares
Change 		Shares
Change %
PA
151
Parallel Advisors
California
– – -1,012 Closed
PNC Financial Services Group
152
PNC Financial Services Group
Pennsylvania
– – -1,000 Closed
US Bancorp
153
US Bancorp
Minnesota
– – -707 Closed
DFCM
154
Dark Forest Capital Management
Puerto Rico
– – -194 Closed
Allspring Global Investments
155
Allspring Global Investments
North Carolina
– – -1 Closed
C
156
Covestor
United Kingdom
– – – –
CFGS
157
Concourse Financial Group Securities
Alabama
– – – –
3 4 5 6
7